Prognostic Significance of Genomic Alterations in Patients With Endometrial Cancer Treated With Carboplatin/Paclitaxel Without or With Avelumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MITO END-3: Efficacy of Avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
Ann. Oncol 2024 May 02;[EPub Ahead of Print], S Pignata, D Califano, D Lorusso, L Arenare, M Bartoletti, U De Giorgi, C Andreetta, C Pisano, G Scambia, D Lombardi, A Farolfi, S Cinieri, A Passarelli, V Salutari, C De Angelis, C Mignogna, D Priolo, ED Capoluongo, S Tamberi, GL Scaglione, V Arcangeli, R De Cecio, G Scognamiglio, F Greco, A Spina, M Turinetto, D Russo, V Carbone, C Casartelli, C Schettino, F PerroneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.